funding is the sole category represented across all 1 tracked stories. Cancer Institute NSW is most often covered alongside Australian-First Cancer Trials Alliance, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Cancer Institute NSW appears in 1 tracked Biotech story from March 8, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Cancer Institute NSW
funding is the sole category represented across all 1 tracked stories. Cancer Institute NSW is most often covered alongside Australian-First Cancer Trials Alliance, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Cancer Institute NSW appears in 1 tracked Biotech story from March 8, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 10 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Cancer Institute NSW. Shared-story counts are live from our verified record — not editorial picks.
The NSW Government has committed significant funding to establish the Australian-First Cancer Trials Alliance (AFCTA), a landmark initiative designed to unify clinical trial infrastructure and accelerate patient access to precision oncology. This strategic investment aims to consolidate fragmented research networks into a single, high-efficiency ecosystem for global biotech and pharmaceutical sponsors.
Cancer Institute NSW is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.